Have a look at our most recent publication published in the Pharmacoepidemiology & Drug Safety journal. The study combines Nordic register data from Denmark, Finland and Sweden with the purpose of comparing users of Finasteride treatment with nonusers. You can read the abstract below, or follow this link to order access to the full article. Abstract [...]
Prof. Anders Green – Appointed Member of the International Scientific Board of the Dasman Diabetes Institute
As of April 1st 2020, Professor Anders Green has been appointed Member of the International Scientific Board of the Dasman Diabetes Institute, Kuwait. The Institute is one of the leading centres in the Middle East for treatment, training and research in diabetes which constitutes a dramatically rising and alarming health problem in the region. As a [...]
Besides leading a workshop on the Nov 6th 09:45-10:45 on Nordic studies based on Nordic pooled data (W19): “Nordic Registries in Safety Studies and Outcome Research”, we will have an oral presentation with Anders Green regarding: “Hospital Costs Before, During, and After Diagnosis of Five Cancer Forms in Denmark During 2014” (ON3: Nov 4th, 16.15-16.30). Furthermore, [...]
Yesterday, ApHER Race Team defied the heat and completed this year’s DHL Relay – the world’s largest relay race in a total time of 2:16:38. It was an evening of great atmosphere and team spirit. We are looking forward to DHL 2020!
Take a look at our most recent publications within 3 areas. Our paper "Electronic Health Lifestyle Coaching Among Diabetes Patients in a Real-Life Municipality Setting: Observational Study" was published in JMIR Diabetes and assessed the effects associated with an eHealth intervention among diabetes patients in a real-life municipal setting. Our study "Finasteride Use and Risk of [...]
The 13th of June Birgitte Holt Andersen and Anastasija Komkova from ApHER attended the kick-off meeting of the EU Horizon 2020 project WOOL2LOOP: Mineral wool in circular economy context. The meeting took place in Helsinki, Finland. Read more about the project here.
Thomas was a speaker at the Nextlevel Life Sciences Conference in Stockholm in May 2019. During the conference, Thomas shared ApHER´s experience of pooling Nordic data
Is your organization ready for the new data demands in the wake of the medical device regulation? Do you know how to build up timely clinical evidence and safety documentation for medical device lcm and market access? This course hosted by MEDICOINDUSTRIEN introduces the concept of real-world evidence (RWE) for medical device products. Full program available [...]
Managing Director Martha Emneus gave an invited presentation at the marketing compliance network meeting of Atrium
On March 13 Managing Director Martha Emneus from ApHER gave an invited presentation at the marketing compliance network meeting of Atrium. The subjects included experience with GDPR as well as linking data in Nordic Register studies. Atrium is part of LIF (The Danish Association of the Pharmaceutical Industry).
A CE-mark is not enough to bring medical device products to the market. Claudia Wild, EUnetHTA member, talks on synergies between medical device regulation (MDR) clinical evidence demand and synergies with HTA processes at the MedTech Access Leaders Forum in Berlin Dec 3-5, 2018. Read more about the event here: https://lnkd.in/gGnXfp5